Search research articles
Contact Us
Filters
Showing results (71-80 of 144) with videos related to
Page
of 15
Sort By:
Plos Medicine
|
May 30, 2017
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis
Alexandra Snyder, Tavi Nathanson, Samuel A Funt, et al.
The Lancet. Oncology
|
August 4, 2023
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
Shubham Pant, Martin Schuler, Gopa Iyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2020
Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer
Sabine Topka, Zoe Steinsnyder, Vignesh Ravichandran, et al.
The American Journal of Surgical Pathology
|
May 29, 2019
PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available Antibodies
Henning Reis, Rene Serrette, Jennifer Posada, et al.
Cancer
|
August 2, 2016
Genomic characterization of response to chemoradiation in urothelial bladder cancer
Neil B Desai, Sasinya N Scott, Emily C Zabor, et al.
European Urology Oncology
|
March 30, 2025
A Phase 1b/2 Study of Talazoparib and Axitinib in Patients with Advanced Clear-cell Renal Cell Carcinoma
Ritesh R Kotecha, Sahil D Doshi, Andrea Knezevic, et al.
Human Pathology
|
March 31, 2018
Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma
Sumit Isharwal, Hongying Huang, Gouri Nanjangud, et al.
European Urology
|
August 6, 2014
Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder
Philip H Kim, Eugene K Cha, John P Sfakianos, et al.
JCO Precision Oncology
|
July 1, 2025
Relationship Among DNA Damage Response Gene Alterations, Molecular Subtypes, and Survival Outcomes in Patients With Metastatic Bladder Cancer Treated on CALGB 90601
Gopa Iyer, Woonyoung Choi, Bin Luo, et al.
Nature Genetics
|
July 18, 2018
Genome doubling shapes the evolution and prognosis of advanced cancers
Craig M Bielski, Ahmet Zehir, Alexander V Penson, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 144) with videos related to
Sort By:
Page
of 15
Plos Medicine
|
May 30, 2017
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis
Alexandra Snyder, Tavi Nathanson, Samuel A Funt, et al.
The Lancet. Oncology
|
August 4, 2023
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
Shubham Pant, Martin Schuler, Gopa Iyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2020
Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer
Sabine Topka, Zoe Steinsnyder, Vignesh Ravichandran, et al.
The American Journal of Surgical Pathology
|
May 29, 2019
PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available Antibodies
Henning Reis, Rene Serrette, Jennifer Posada, et al.
Cancer
|
August 2, 2016
Genomic characterization of response to chemoradiation in urothelial bladder cancer
Neil B Desai, Sasinya N Scott, Emily C Zabor, et al.
European Urology Oncology
|
March 30, 2025
A Phase 1b/2 Study of Talazoparib and Axitinib in Patients with Advanced Clear-cell Renal Cell Carcinoma
Ritesh R Kotecha, Sahil D Doshi, Andrea Knezevic, et al.
Human Pathology
|
March 31, 2018
Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma
Sumit Isharwal, Hongying Huang, Gouri Nanjangud, et al.
European Urology
|
August 6, 2014
Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder
Philip H Kim, Eugene K Cha, John P Sfakianos, et al.
JCO Precision Oncology
|
July 1, 2025
Relationship Among DNA Damage Response Gene Alterations, Molecular Subtypes, and Survival Outcomes in Patients With Metastatic Bladder Cancer Treated on CALGB 90601
Gopa Iyer, Woonyoung Choi, Bin Luo, et al.
Nature Genetics
|
July 18, 2018
Genome doubling shapes the evolution and prognosis of advanced cancers
Craig M Bielski, Ahmet Zehir, Alexander V Penson, et al.
Page
of 15